Long-term hepatitis B viral infection in a novel, scalable primary hepatocyte system.
Led by Alexander Ploss, Ph.D., Princeton University.
August 8, 2017; 1:30PM GMT & 2:00PM EDT
register – coming soon
Nature Communications publication marks launch of HµRELviralTM infectious liver disease platform (download press release – coming soon)
21st North American ISSX Meeting
September 24-28, 2017
HµREL® featured in news article on New Jersey – based biotechs. (download article)
HµREL® Corporation Opens New, Expanded Laboratories and Corporate Headquarters in North Brunswick, New Jersey. (download press release)
HµREL® Providing Microliver Models To EPA TOXCAST Program. (download press release)
AstraZeneca: HµREL® “Superior” for studying low-CLint Compounds. (view summary)
Optivia Biotechnology Forms Technology and Marketing Alliance with HµREL® Corporation. (download press release)
ACEA Biosciences and HµREL® Corporation Announce Joint Marketing of
Integrated Product Kits. (download press release)
HµREL® Corporation Completes Investment from Johnston Associates, Inc. (download press release)